The Prescription Drug User Fee Act target guidelines for NDA resubmissions include acknowledgment of acceptance for review within 30 days of submission, and completion of submission review within 6 ...
The 2026 Grade 10 admission process has been scheduled with clear reporting timelines and documentation requirements for ...